Where is there opportunity?
Everything we do is aimed at clarifying diagnosis and eliminating uncertainty for patients. The opportunities with genomics are endless, and we are paving the way so every patient will have the answers they seek.
Real People,
Real Science,
Real Answers.
JOHN HANNA
Chief Commercial Officer
Veracyte
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Highlighted by National Cancer Institute
NCI highlights lung cancer early detection work behind Percepta in its annual plan
learn more >
Evidence That Sets New Standards
Veracyte’s CEO Receives 2017 Wallace H. Coulter Award for Healthcare Innovation

learn more >


latest news
news and updates
Oct 20, 2017
Veracyte Announces Presentation of New Data Validating Accuracy of BRAF V600E and Parathyroid Tissue Classifiers at ATA Annual Meeting

learn more >
Oct 19, 2017
Veracyte Announces New Data Demonstrating Clinical Utility of Percepta Bronchial Genomic Classifier to be Presented at CHEST Annual Meeting 2017

learn more >
Oct 13, 2017
Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting

learn more >